GlassScriptPhysician profile
Yong Jun Cho
NPI 1083146203
$1,723.91
in general payments reported to CMS, 2019-2025
14 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,242 · 2022: $38.30 · 2023: $229 · 2024: $114 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2021 | |
| Heron Therapeutics, INC. | $132.23 | 2022-2023 | Zynrelef |
| Polynovo North America LLC | $70.03 | 2024 | Novosorb Btm |
| Smith+Nephew, INC. | $68.55 | 2022-2024 | Collagenase Santyl |
| Next Science LLC | $51.53 | 2023 | Xperience, Blastx, Surgx |
| Teleflex LLC | $34.10 | 2025 | Arrow |
| Orthofix Medical, INC. | $24.78 | 2025 | Physio-Stim |
| Averitas Pharma INC. | $23.20 | 2023 | Qutenza |
| Zimmer Biomet Holdings, INC. | $22.79 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.35 | 2025 | Jublia |
| Paratek Pharmaceuticals, INC. | $20.32 | 2025 | Nuzyra |
| Advanced Oxygen Therapy INC. | $19.52 | 2021 | |
| Reprise Biomedical, INC. | $18.29 | 2024 | Miro3d |
| Endo Pharmaceuticals INC. | $17.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yong Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.